{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380286994102757504.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"S Kaneko"}],"foaf:familyName":[{"@value":"Kaneko"}],"foaf:givenName":[{"@value":"S"}]}],"career":[{"institution":{"notation":[{"@value":"Japan Development, Biostatistics Pharma, Integrated Biostatistics Japan, Novartis Pharma K.K., Minato-ku, Tokyo, Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360286994102757504","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/10543406.2020.1744619"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/10543406.2020.1744619"},{"@type":"DOI","@value":"10.6084/m9.figshare.12159042"},{"@type":"DOI","@value":"10.6084/m9.figshare.12159042.v1"},{"@type":"PMID","@value":"32310707"}],"notation":[{"@value":"A dose-finding approach for genomic patterns in phase I trials"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1080/10543406.2020.1744619_5NRYd8Hhqt52g9UuphjBrjpvYRR"}]}